What Researchers Did
Researchers conducted a systematic review and meta-analysis of nine randomized clinical trials involving 585 participants to assess the efficacy of hyperbaric oxygen therapy for healing diabetes-related lower limb ulcers.
What They Found
Patients receiving hyperbaric oxygen therapy were significantly more likely to achieve complete ulcer healing (relative risk 1.95, P<0.001) compared to control groups. They also experienced a reduced risk of major (relative risk 0.54, P=0.003) and minor (relative risk 0.68, P=0.040) amputations. However, sensitivity analyses indicated that these findings were dependent on the inclusion of a single trial.
What This Means for Canadian Patients
For Canadian patients with diabetes-related lower limb ulcers, hyperbaric oxygen therapy may offer a beneficial treatment option to promote healing and potentially avoid amputations. Patients should discuss this therapy with their healthcare providers to understand its potential benefits and risks, such as ear barotrauma.
Canadian Relevance
This meta-analysis did not include any studies specifically conducted in Canada, so direct Canadian relevance is not established.
Study Limitations
The confidence in these results is limited by significant methodological weaknesses in the included trials, such as lack of blinding, inadequate sample size calculations, and limited follow-up.